Coverage
-
September 17, 2021
A Pennsylvania federal judge has granted final approval for an award of $1.3 million in fees to attorneys from Pomerantz LLP, the Rosen Law Firm and Bronstein Gewirtz & Grossman LLC for securing a $4 million settlement on behalf of investors in CBD drugmaker Zynerba Pharmaceuticals Inc.
5 other articles on this case.
View all »